Association of p53 arginine polymorphism with skin cancer

Background  The presence of arginine at codon 72 in p53 protein is proposed to be a genetic risk factor in human papillomavirus (HPV)‐related carcinogenesis.

[1]  H. Pfister,et al.  In vitro expressed HPV 8 E 6 protein does not bind p 53 , 2005, Archives of Virology.

[2]  C. Festa Neto,et al.  Clinical aspects of epidermodysplasia verruciformis , 2003, Journal of the European Academy of Dermatology and Venereology : JEADV.

[3]  B. Akgül,et al.  Dual role of tumor suppressor p53 in regulation of DNA replication and oncogene E6-promoter activity of epidermodysplasia verruciformis-associated human papillomavirus type 8. , 2003, Virology.

[4]  S. Carrasco,et al.  Nonspecific Cell‐Mediated Immunity in Patients with Epidermodysplasia Verruciformis , 2003, The Journal of dermatology.

[5]  S. Tyring,et al.  Seborrheic Keratosis‐like Lesions in Patients with Epidermodysplasia Verruciformis , 2003, The Journal of dermatology.

[6]  N. Ramoz,et al.  Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis , 2002, Nature Genetics.

[7]  S. Fisher,et al.  Relationship between p53 codon 72 polymorphism and susceptibility to sunburn and skin cancer. , 2002, The Journal of investigative dermatology.

[8]  S. Jabłońska,et al.  Do epidermodysplasia verruciformis human papillomaviruses contribute to malignant and benign epidermal proliferations? , 2002, Archives of dermatology.

[9]  N. Ramoz,et al.  Mutation and abnormal expression of the p53 gene in the viral skin carcinogenesis of epidermodysplasia verruciformis. , 2001, The Journal of investigative dermatology.

[10]  N. Dalay,et al.  P53 codon 72 genotypes in colon cancer. Association with human papillomavirus infection. , 2001, Research communications in molecular pathology and pharmacology.

[11]  E. Kay,et al.  p53 codon 72 polymorphism and human papillomavirus associated skin cancer , 2001, Journal of clinical pathology.

[12]  R. Westendorp,et al.  Cutaneous squamous cell carcinoma and p53 codon 72 polymorphism: A need for screening? * , 2001, Molecular carcinogenesis.

[13]  N. Ramoz,et al.  Evidence for a nonallelic heterogeneity of epidermodysplasia verruciformis with two susceptibility loci mapped to chromosome regions 2p21-p24 and 17q25. , 2000, The Journal of investigative dermatology.

[14]  D. Spandidos,et al.  P53 codon 72 polymorphism as a risk factor in the development of HPV-associated non-melanoma skin cancers in immunocompetent hosts. , 2000, International journal of molecular medicine.

[15]  S. Marshall,et al.  p53 codon 72 polymorphism and susceptibility to skin cancer after renal transplantation. , 2000, Transplantation.

[16]  G. Voglino,et al.  Codon 72 polymorphism of p53 and its association with cervical cancer , 1999, The Lancet.

[17]  N. Ramoz,et al.  A susceptibility locus for epidermodysplasia verruciformis, an abnormal predisposition to infection with the oncogenic human papillomavirus type 5, maps to chromosome 17qter in a region containing a psoriasis locus. , 1999, The Journal of investigative dermatology.

[18]  C-Y Chen,et al.  Prognostic significance of p53 codon 72 polymorphism in lung carcinomas. , 1999, European journal of cancer.

[19]  Miranda Thomas,et al.  Two Polymorphic Variants of Wild-Type p53 Differ Biochemically and Biologically , 1999, Molecular and Cellular Biology.

[20]  Irene M. Leigh,et al.  Role of a p53 polymorphism in the development of human papilloma-virus-associated cancer , 1998, Nature.

[21]  E. Villiers.  Human papillomavirus infections in skin cancers , 1998 .

[22]  H. zur Hausen.  Papillomavirus and p53 , 1998, Nature.

[23]  E. de Villiers.  Human papillomavirus infections in skin cancers. , 1998, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[24]  T. Iftner,et al.  A comparative analysis of the interactions of the E6 proteins from cutaneous and genital papillomaviruses with p53 and E6AP in correlation to their transforming potential. , 1997, Virology.

[25]  Z. H. Hafeez,et al.  Epidermodysplasia verruciformis. , 1996, JPMA. The Journal of the Pakistan Medical Association.

[26]  S. Jabłońska,et al.  Epidermodysplasia verruciformis as a model of human papillomavirus-induced genetic cancer of the skin. , 1995, Archives of dermatology.

[27]  E. Healy,et al.  High frequency of loss of heterozygosity in actinic keratoses, a usually benign disease , 1994, The Lancet.

[28]  R. Birgander,et al.  Is p53 polymorphism maintained by natural selection? , 1994, Human heredity.

[29]  J. Rees,et al.  Basal cell carcinomas and squamous cell carcinomas of human skin show distinct patterns of chromosome loss. , 1994, Cancer research.

[30]  S. Jabłońska,et al.  Epidermodysplasia verruciformis: immunological and clinical aspects. , 1994, Current topics in microbiology and immunology.

[31]  S. Jabłońska,et al.  Epidermodysplasia verruciformis as a model of human papillomavirus-induced genetic cancers: the role of local immunosurveillance. , 1992, The American journal of the medical sciences.

[32]  F. Scinicariello,et al.  p53 mutations in basal cell carcinomas. , 1992, Cancer research.

[33]  T. Iftner,et al.  Involvement of human papillomavirus type 8 genes E6 and E7 in transformation and replication , 1988, Journal of virology.